| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Total Revenue | $722M (+117% YoY Q4) | $783M (+86% YoY Q1) | Solid acceleration despite tough comps |
| CELSIUS Revenue | $325M (-7.7% YoY Q4) | $348M (+6% YoY Q1) | Improvement but still tepid growth |
| Alani Nu Revenue | $370M (136% pro forma Q4) | $368M (60% reported, 85% organic Q1) | Growth moderating as base scales |
| Rockstar Revenue | $45M net sales Q4 | $67M Q1 | +49% sequential improvement |
| Gross Margin | 47.4% Q4 | 48.3% Q1 | +90bps sequential recovery |
| Adjusted EBITDA Margin | 18.6% Q4 | 24.9% Q1 | +630bps massive improvement |
| Adjusted SG&A % | 31.8% Q4 | 26.4% Q1 | -540bps operating leverage |
| Net Income | $24.7M Q4 | $110M Q1 | +345% earnings acceleration |
| GAAP EPS | Not disclosed Q4 | Not disclosed Q1 | Still avoiding EPS disclosure |
| Cash Position | $399M Q4 | Not disclosed Q1 | Stopped reporting cash balance |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.